Category: 2022 Year in Review - Psychedelic Alpha

A Perspective from the ‘Reimagining Psychedelic Trials’ Working Group

Historical Insights on the Psychedelic Renaissance

A Spotlight on Psychedelic Research Methods

Panel: Psychedelic Research Methods

The Agenda for Economic Analyses of Psychedelic-assisted Therapy

A Perspective on Providers: Scaling PAT in a Time of Therapist Shortages

Making “Access” A Meaningful Part of Every Conversation about Psychedelic Therapy

Psychedelic Therapies: From Approvals to Access

Kabir Nath: Our Mission, Progress and Future Perspectives

Late-Stage Psychedelic Trials: A brief review of the two most mature psychedelic drug development programs

Weekly Bulletin

Research Review

News & Interviews

Psychedelics Patent Trackers

Psychedelic Legalization & Decriminalization Tracker

Psychedelics Drug Development Tracker

Stocks & Companies Directory

Sector Landscape Map

Stock Watchlist

A Perspective from the ‘Reimagining Psychedelic Trials’ Working Group

Historical Insights on the Psychedelic Renaissance

A Spotlight on Psychedelic Research Methods

Panel: Psychedelic Research Methods

The Agenda for Economic Analyses of Psychedelic-assisted Therapy

A Perspective on Providers: Scaling PAT in a Time of Therapist Shortages

Making “Access” A Meaningful Part of Every Conversation about Psychedelic Therapy

Psychedelic Therapies: From Approvals to Access

Kabir Nath: Our Mission, Progress and Future Perspectives

Late-Stage Psychedelic Trials: A brief review of the two most mature psychedelic drug development programs

Psychedelic Alpha

Quick Links

Newsletter

Join Our Newsletter

Psychedelic sector insights, interviews and analysis delivered to your inbox.

No thanks, continue to site.